S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman Sells 1,000 Shares

Nu Skin Enterprises, Inc. (NYSE:NUS - Get Rating) Director Andrew D. Lipman sold 1,000 shares of the firm's stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $36.67, for a total value of $36,670.00. Following the transaction, the director now owns 69,393 shares in the company, valued at $2,544,641.31. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Nu Skin Enterprises Stock Down 0.3 %

Shares of Nu Skin Enterprises stock traded down $0.12 during trading on Thursday, reaching $36.85. The company's stock had a trading volume of 287,367 shares, compared to its average volume of 559,714. The company has a quick ratio of 1.38, a current ratio of 2.30 and a debt-to-equity ratio of 0.41. The company has a market cap of $1.85 billion, a price-to-earnings ratio of 16.60 and a beta of 1.16. Nu Skin Enterprises, Inc. has a 1-year low of $36.32 and a 1-year high of $56.76. The company has a 50-day simple moving average of $42.16 and a two-hundred day simple moving average of $44.56.

Nu Skin Enterprises Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 7th. Stockholders of record on Friday, August 26th were given a $0.385 dividend. The ex-dividend date of this dividend was Thursday, August 25th. This represents a $1.54 dividend on an annualized basis and a dividend yield of 4.18%. Nu Skin Enterprises's payout ratio is 69.37%.

Institutional Trading of Nu Skin Enterprises


A number of institutional investors have recently made changes to their positions in the business. State Street Corp boosted its position in shares of Nu Skin Enterprises by 40.5% in the 2nd quarter. State Street Corp now owns 9,161,235 shares of the company's stock worth $396,681,000 after purchasing an additional 2,640,656 shares in the last quarter. BlackRock Inc. lifted its position in Nu Skin Enterprises by 0.5% during the 1st quarter. BlackRock Inc. now owns 5,791,181 shares of the company's stock worth $277,281,000 after acquiring an additional 30,340 shares during the period. Renaissance Technologies LLC lifted its position in Nu Skin Enterprises by 5.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,819,396 shares of the company's stock worth $122,080,000 after acquiring an additional 148,400 shares during the period. Dimensional Fund Advisors LP lifted its position in Nu Skin Enterprises by 4.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,709,894 shares of the company's stock worth $81,869,000 after acquiring an additional 72,030 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Nu Skin Enterprises by 1.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 921,772 shares of the company's stock worth $46,780,000 after acquiring an additional 9,127 shares during the period. Institutional investors and hedge funds own 88.20% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. StockNews.com upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Wednesday, June 22nd. DA Davidson cut their price target on Nu Skin Enterprises from $45.00 to $40.00 and set a "neutral" rating on the stock in a report on Tuesday, August 23rd. Citigroup lifted their price target on Nu Skin Enterprises from $45.00 to $47.00 and gave the company a "neutral" rating in a report on Monday, August 8th. Finally, TheStreet downgraded Nu Skin Enterprises from a "b" rating to a "c" rating in a report on Thursday, August 4th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $58.50.

About Nu Skin Enterprises

(Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Stories

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Nu Skin Enterprises right now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.